Huimin Zhou

Huimin Zhou

Auto-generated profile, based on publicly available information

Huimin Zhou

College of Basic Medicine Shanxi Medical University Taiyuan 030001 Shanxi China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2022 in ChemMedChem
Verified
Journal Article
Open access
PDF file
YLYanan Li
Yanan Li
JCJing Cui
Jing Cui
CLChenlong Li
Chenlong Li
HZHuimin Zhou
Huimin Zhou
JCJun Chang
Jun Chang
FAFeifei An
Feifei An
Fluorine magnetic resonance imaging (19F MRI) is a promising imaging technique for cancer diagnosis because of its excellent soft tissue resolution and deep tissue penetration, as well as the inherent high natural abundance, almost no endogenous interference, quantitative analysis, and wide chemical shift range of the 19F nucleus. In recent years, scientists have synthesized various 19F MRI contrast agents. By further integrating a wide variety of nanomaterials and cutting‐edge construction strategies, magnetically equivalent 19F atoms are super‐loaded and maintain satisfactory relaxation efficiency to obtain high‐intensity 19F MRI signals. In this review, the nuclear magnetic resonance principle underlying 19F MRI is first described. Then, the construction and performance of various fluorinated contrast agents are summarized. Finally, challenges and future prospects regarding the clinical translation of 19F MRI nanoprobes are considered. This review will provide strategic guidance and panoramic expectations for designing new cancer theranostic regimens and realizing their clinical translation.